LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Pathology

Image: A histologic view of an endometrial adenocarcinoma showing many abnormal nuclei (Photo courtesy of Wikimedia Commons).

Study Finds Five New Genetic Risk Loci for Endometrial Cancer

Genome-wide association studies (GWAS) have revealed five previously unknown risk loci for endometrial cancer. More...
16 May 2016
Image: A structural model of the Bim protein (Photo courtesy of Wikimedia Commons).

Levels of Bim Protein in T-cells Reflect Success of Anti–PD-1 Cancer Therapy

Measurement of levels of Bim (BCL-2-interacting mediator of cell death) protein in circulating T-cells of cancer patients may provide a less invasive strategy to predict and monitor responses to anti–PD-1 therapy. More...
16 May 2016
Image: The MRX microplate reader (Photo courtesy of Dynatech Medical Products).

Blood Test Detects Breast Cancer Spread Earlier

More sensitive, non-invasive tests are required for secondary breast cancer, which occurs when new tumors grow in the bone, liver, lung or brain, to make diagnosis easier and for treatment to begin as early as possible. More...
12 May 2016
Image: The MassARRAY Dx analyzer system (Photo courtesy of Agena Bioscience).

Diagnostic Tests For Lung And Colon Cancer Launched In Europe

A unique combination of reliability, sensitivity, ease of use, and cost-effectiveness for targeted genetic testing for cancer has now become available to molecular pathologists. More...
12 May 2016

Blood Test Developed for Parkinson’s Disease

Currently no clinical biomarker test exists for Parkinson's and the only means of diagnosis is a neurological examination and by the time patients develop symptoms and undergo the examination, large numbers of vital brain cells have already been destroyed. More...
12 May 2016
Image: A diagram of the NuQ biomarker assay for prostate cancer (Photo courtesy of VolitionRx).

Blood Biomarker Assay Detects Prostate Cancer Early

Approximately 14% of men will be diagnosed with prostate cancer at some point during their lifetime and nearly three million men are estimated to be living with prostate cancer in the USA alone. More...
12 May 2016
Image: A histopathology of prostate cancer showing multiple poorly formed glands with ill-defined lumina and/or incomplete nuclear complement, Gleason score 3+4 = 7 (Photo courtesy of European Urology).

Non-Invasive Prostate Cancer Test Developed Using Exosomal RNA

The current screening paradigm for prostate cancer faces challenges that lead to unnecessary biopsies and, ultimately, overtreatment. The disadvantage of Prostate-Specific Antigen (PSA) testing is lack of specificity for prostate cancer resulting in both false positive and false negative results. More...
11 May 2016
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Electrolyte Analyzer
CBS-4000 (CBS-400)


The Pathology channel details advances in the field of Surgical Pathology and all its subspecialties, including Cytopathology and its subspecialties.
ADLM